Announcing the First Novel Class of Rapid-Onset Antidepressants in Clinical Practice

Olumuyiwa John Fasipe ； Peter Ehizokhale Akhideno ； Omagbemi Sampson Owhin ； Oluwatosin Beatrice Ibiyemi-Fasipe

《Journal of Medical Sciences》 39卷5期 (2019/10) Pp. 205-216

https://doi.org/10.4103/jmedsci.jmedsci_36_19

摘要

This study was designed with the rational aim/purpose of announcing and discussing the new class of rapid-onset antidepressants that will bring forth significant improvement and positive impact to the management of patients with depression disorders in clinical practice. The class of N-methyl-D-aspartate-glutamatergic ionoceptor blockers represent the first separate novel class of rapid-onset antidepressants with a direct action on the excitatory glutamatergic neurotransmission system but no direct action on the serotonergic, noradrenergic, or dopaminergic neurotransmission systems. It consistently fits into the antidepressants' classification nomenclature, and the pharmacological properties also deemed it appropriate to be accepted and announced as the first separate novel class of rapid-onset antidepressants.

關鍵字

First separate novel class of rapid-onset antidepressants ； glutamatergic neurotransmission blockers ； depressive disorders